The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

Secondary analyses showed that APOE ε4 carriers were also at greater risk for intraparenchymal hemorrhage (HR, 3.70; 95% CI, 1.36-8.38), though no significant differences were observed for ischemic ...

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.

HealthDay News — Adults with hearing loss (HL) with hearing aids have a reduced risk for dementia, according to a research letter published online Aug. 18 in JAMA Neurology.

The researchers found that students with autism reported significantly higher rates of anxiety (64.5 percent) and depression (48.2 percent) versus peers without autism (9.4 and 7.6 percent, ...

From 2013 to 2018, older adults with heart failure, stroke, and hypertension experienced significant declines in LE8 scores.

The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.

Risk for retinal vein occlusion (RVO) is higher among patients with obstructive sleep apnea (OSA), according to results of a retrospective cohort study published in Eye.

The AHA and the ACC have jointly released an updated guideline on the prevention and management of high blood pressure in adults.

Patients with PD may experience improvements in sleep quality, daytime sleepiness, and total sleep time with melatonin.

Bacterial infections in the first week of life significantly increase the risk of developing epilepsy in childhood.

Blood-based biomarker testing may aid in diagnosing Alzheimer disease (AD) in specialized care settings, according to a newly published Alzheimer’s Association Clinical Practice Guideline in Alzheimer ...